famotidine has been researched along with bismuth in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colombo, E; Fanti, L; Guslandi, M; Masci, E; Testoni, PA; Tittobello, A | 1 |
| Lee, WY; Lin, JT; Wang, JT; Wang, TH; Wu, MS; Yang, JC | 1 |
| Battaglia, G; Di Mario, F; Grasso, G; Leandro, G; Vianello, F; Vigneri, S | 1 |
1 review(s) available for famotidine and bismuth
| Article | Year |
|---|---|
Short-term treatment of gastric ulcer. A meta-analytical evaluation of blind trials.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Cimetidine; Controlled Clinical Trials as Topic; Famotidine; Histamine H2 Antagonists; Humans; Placebos; Ranitidine; Stomach Ulcer; Sucralfate; Time Factors | 1996 |
2 trial(s) available for famotidine and bismuth
| Article | Year |
|---|---|
Colloid bismuth versus famotidine in the treatment and prevention of duodenal ulcer relapse: results of a double-blind, double dummy randomized study.
Topics: Antacids; Anti-Ulcer Agents; Bismuth; Colloids; Double-Blind Method; Duodenal Ulcer; Endoscopy, Gastrointestinal; Famotidine; Helicobacter pylori; Humans; Recurrence | 1995 |
Prospective, randomized study of H2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence | 1994 |